Tailored modulation of the inflammatory balance in COVID-19 patients admitted to the ICU?-a viewpoint.
Crit Care
; 25(1): 178, 2021 05 25.
Article
in English
| MEDLINE | ID: covidwho-1243817
ABSTRACT
A growing consensus seems to be emerging that dexamethasone is a crucial component in the treatment of COVID-19-associated oxygen-dependent respiratory failure. Although dexamethasone has an undeniably beneficial effect on the inflammatory response in a subgroup of patients, the potential negative effects of corticosteroids must also be considered. In view of these negative effects, we argue that a one-size-fits-all dexamethasone approach may be potentially harmful in specific subsets of patients with COVID-19-associated ARDS. We propose a different individually tailored treatment strategy based on the patient's inflammatory response.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Respiratory Insufficiency
/
Dexamethasone
/
Critical Care
/
COVID-19 Drug Treatment
/
Inflammation
Type of study:
Prognostic study
Topics:
Long Covid
Limits:
Humans
Language:
English
Journal:
Crit Care
Year:
2021
Document Type:
Article
Affiliation country:
S13054-021-03607-4
Similar
MEDLINE
...
LILACS
LIS